| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Esperion Therapeutics, Inc. (ESPR) has 9 insiders with recent SEC Form 4 filings, including 5 buys and 18 sells. ESPR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.47M | $4.65M | - | |
| CFO | 467.5K | $1.48M | - | |
| Other | 385.9K | $1.22M | - | |
| Other | 380.0K | $1.20M | - | |
| Dir | 177.5K | $561.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 17, 2018 | Biotech Target N V55 | 10% Owner | Buy | 60,000 | $47.73 | $2,864,070.00 | +1.8% | |
| Nov 5, 2018 | Boxer Capital, LLC79 | 10% Owner | Sell | 100,000 | $56.38 | $5,638,342.60 | -1.1% | |
| Nov 2, 2018 | Newton Roger S | Director | Sell | 2,827 | $50.07 | $141,548.52 | -0.2% | |
| Oct 18, 2018 | Newton Roger S | Director | Sell | 22,173 | $50.02 | $1,108,997.46 | -1.3% | |
| Aug 27, 2018 | Newton Roger S | Director | Sell | 17,700 | $51.05 | $903,610.00 | -0.7% | |
| Aug 17, 2018 | Newton Roger S | Director | Sell | 7,300 | $50.06 | $365,438.00 | -1.2% | |
| Aug 3, 2018 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $46.14 | $2,306,970.00 | +1.5% | |
| Jul 12, 2018 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $41.77 | $2,088,300.00 | +1.6% | |
| Jun 29, 2018 | Biotech Target N V55 | 10% Owner | Buy | 50,000 | $39.48 | $1,973,805.00 | +1.6% | |
| Jun 21, 2018 | Biotech Target N V55 | 10% Owner | Buy | 60,000 | $38.57 | $2,314,224.00 | +2.0% |